MARSHALL WACE, LLP - MEDTECH ACQUISITION CORP ownership

MEDTECH ACQUISITION CORP's ticker is MTAC and the CUSIP is 58507N105. A total of 10 filers reported holding MEDTECH ACQUISITION CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of MEDTECH ACQUISITION CORP
ValueSharesWeighting
Q3 2022$7,900,000
+0.9%
795,5190.0%0.02%
+6.2%
Q2 2022$7,829,000
+0.4%
795,5190.0%0.02%
+6.7%
Q1 2022$7,795,000
-0.8%
795,5190.0%0.02%0.0%
Q4 2021$7,858,000
-4.5%
795,519
-4.0%
0.02%
-55.9%
Q3 2021$8,232,000
+3.4%
828,955
+1.6%
0.03%
-5.6%
Q2 2021$7,965,000
+15.3%
816,086
+14.0%
0.04%
+12.5%
Q1 2021$6,910,000716,0860.03%
Other shareholders
MEDTECH ACQUISITION CORP shareholders Q4 2022
NameSharesValueWeighting ↓
MYDA Advisors LLC 403,070$3,910,0000.98%
Park West Asset Management LLC 1,250,000$12,125,0000.34%
SPRING CREEK CAPITAL LLC 503,600$4,885,0000.24%
ARISTEIA CAPITAL, L.L.C. 1,153,485$11,189,0000.22%
CVI Holdings, LLC 250,000$2,425,0000.16%
Context Capital Management, LLC 174,065$1,688,0000.16%
K.J. Harrison & Partners Inc 140,000$1,359,0000.14%
Radcliffe Capital Management, L.P. 414,584$4,021,0000.13%
Omni Partners US LLC 220,971$2,143,0000.09%
Vestcor Inc 276,074$2,694,0000.09%
View complete list of MEDTECH ACQUISITION CORP shareholders